Quantcast

Latest News

Discovery Holds Key to Boosting Brain’s Ability to Fight Alzheimer’s, MS

UVA Health researchers have discovered a molecule in the brain responsible for orchestrating the immune system’s responses to Alzheimer’s disease and multiple sclerosis (MS), potentially allowing doctors to supercharge the body’s ability to fight those and other devastating neurological diseases.

Minorities Face Longer Waits for Vital Lung Cancer Treatment: Study

A new study has revealed significant racial disparities in how quickly minorities with the most common form of lung cancer receive potentially lifesaving radiation therapy compared with their white counterparts.

UVA Creates Shining ‘KSTAR’ to Guide Cancer Treatments

UVA Health Cancer Center researchers have developed an algorithm that will improve cancer care by quickly and easily identifying patients who will benefit from powerful cancer drugs called kinase inhibitors.

Common Antibiotic Can Reduce Risk of Death During Childbirth

A single dose of the antibiotic azithromycin can help protect mothers from dangerous sepsis infections and death during vaginal childbirth, a sweeping new international study from a UVA Health scientist and his collaborators has found.

UVA Discovers Potential New Way to Prevent Vision Loss

UVA Health scientists have discovered an unknown contributor to harmful blood vessel growth in the eye that could lead to new treatments for blinding macular degeneration and other common causes of vision loss.

UVA IDs Trigger for World’s Most Common Liver Disease

School of Medicine researchers have discovered a key trigger for non-alcoholic fatty liver disease, a mysterious condition that causes fat to build up in the liver for no clear reason.

UVA IDs Genes Responsible for Coronary Artery Disease

UVA researchers and their collaborators have identified genes that play key roles in the development of coronary artery disease, the No. 1 cause of death worldwide.

Menstrual Symptoms Hurt Workplace Productivity of Many Women, UVA Health Study Finds

Menstrual symptoms reduce the workplace productivity of many American women, with 45.2% reporting that their symptoms require them to take days off, according to a new UVA Health survey.

UVA Solves Mysteries about Leading Biomarker for Alzheimer’s

Tau protein is notorious for forming tangles in the brains of people with Alzheimer’s disease and several other neurodegenerative disorders, and for helping to cause cognitive decline associated with those diseases.

COVID-19 Booster Increases Durability of Antibody Response

New research from the University of Virginia School of Medicine speaks to the benefits of a COVID-19 booster.

Potentially Deadly Infection Has Dangerous Ally Lurking in Our Guts

New research from the School of Medicine and collaborators reveals how microorganisms found in our guts can worsen dangerous C. difficile infections.

Antidepressants, Infection Linked to Neurodevelopmental Disorders

Antidepressant use may combine with inflammation during pregnancy to heighten the risk of lifelong neurodevelopmental changes in babies’ brains, such as those linked to autism, new research from the University of Virginia School of Medicine suggests.

UVA Discovery to Improve Drug Development

A surprising discovery from the School of Medicine has torpedoed a key principle used in the development of new drugs to treat diseases.

UVA Creates Potent Tool to Advance Genomics, Disease Research

UVA Health researchers have developed an important new tool to help scientists sort signal from noise as they probe the genetic causes of cancer and other diseases.

Focused Ultrasound Treatment for Essential Tremor Highly Effective After 5 Years

A scalpel-free, high-tech form of brain surgery pioneered at UVA Health offers long-term relief for patients with essential tremor, a common movement disorder, a five-year review shows.

UVA Blood Cancer Research Points to New Treatment for Bone Marrow Cancer

Pioneering research into the chronic inflammation often seen in certain blood cancers has identified a promising treatment approach for myelofibrosis, a potentially deadly bone marrow cancer.